• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ron Ellis - Articles and news items

Merck logo
Merck logo

Exclusive worldwide agreement to develop and commercialize Phase III cancer candidate vintafolide (EC145)

Industry news, News / 16 April 2012 / Merck

Vintafolide is currently being evaluated in a Phase III clinical trial…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +